Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group.
Comella P, Crucitta E, De Vita F, De Lucia L, Farris A, Del Gaizo F, Palmeri S, Lannelli A, Mancarella S, Tafuto S, Maiorino L, Buzzi F, De Cataldis G; Associated Institutions of the Southern Italy Cooperative Oncology Group. Comella P, et al. Among authors: del gaizo f. Ann Oncol. 2002 Jun;13(6):866-73. doi: 10.1093/annonc/mdf133. Ann Oncol. 2002. PMID: 12123331 Free article. Clinical Trial.
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia.
Frasci G, Comella P, Panza N, De Cataldis G, Del Gaizo F, Pozzo C, Gravina A, Ruffolo P, Cioffi R, Marcatili P, Della Vittoria M, Monfardini S, Comella G. Frasci G, et al. Among authors: del gaizo f. Eur J Cancer. 1998 Oct;34(11):1710-4. doi: 10.1016/s0959-8049(98)00207-x. Eur J Cancer. 1998. PMID: 9893657 Clinical Trial.
Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha.
Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S. Pedrazzoli P, et al. Among authors: del gaizo f. J Clin Oncol. 2008 Apr 1;26(10):1619-25. doi: 10.1200/JCO.2007.12.2051. J Clin Oncol. 2008. PMID: 18375891 Clinical Trial.
Chemotherapy of advanced NSCLC in special patient population.
Gridelli C, Maione P, Rossi A, Guerriero C, Ferrara C, Del Gaizo F, Colantuoni G, Nicolella D, Napolitano L. Gridelli C, et al. Among authors: del gaizo f. Ann Oncol. 2006 May;17 Suppl 5:v72-8. doi: 10.1093/annonc/mdj955. Ann Oncol. 2006. PMID: 16807469 Free article. Review.
Italian clinical research in non-small-cell lung cancer.
Gridelli C, Rossi A, Galetta D, Maione P, Ferrara C, Guerriero C, Del Gaizo F, Nicolella D, Colantuoni G, Gebbia V, Colucci G. Gridelli C, et al. Among authors: del gaizo f. Ann Oncol. 2005 May;16 Suppl 4:iv110-115. doi: 10.1093/annonc/mdi919. Ann Oncol. 2005. PMID: 15923410 Free article.
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial.
Pignata S, Scambia G, Savarese A, Breda E, Scollo P, De Vivo R, Rossi E, Gebbia V, Natale D, Del Gaizo F, Naglieri E, Ferro A, Musso P, D'Arco AM, Sorio R, Pisano C, Di Maio M, Signoriello G, Annunziata A, Perrone F; MITO Investigators. Pignata S, et al. Among authors: del gaizo f. BMC Cancer. 2006 Aug 1;6:202. doi: 10.1186/1471-2407-6-202. BMC Cancer. 2006. PMID: 16882344 Free PMC article. Clinical Trial.
Treatment of small cell lung cancer in the elderly.
Rossi A, Maione P, Colantuoni G, Guerriero C, Ferrara C, Del Gaizo F, Nicolella D, Gridelli C. Rossi A, et al. Among authors: del gaizo f. Oncologist. 2005 Jun-Jul;10(6):399-411. doi: 10.1634/theoncologist.10-6-399. Oncologist. 2005. PMID: 15967834 Free article. Review.
Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer.
Gridelli C, Maione P, Del Gaizo F, Colantuoni G, Guerriero C, Ferrara C, Nicolella D, Comunale D, De Vita A, Rossi A. Gridelli C, et al. Among authors: del gaizo f. Oncologist. 2007 Feb;12(2):191-200. doi: 10.1634/theoncologist.12-2-191. Oncologist. 2007. PMID: 17296815 Free article.
19 results